Why Did Biohaven Soar 12.6%? Positive Analyst Outlook, Institutional Buying
On August 22, 2025, Biohaven's stock surged by 12.6% in pre-market trading, marking a significant rise that has caught the attention of investors and analysts alike.
BTIG Research recently revised its target price for BiohavenBHVN--, increasing it from $59.00 to $60.00 and maintaining a "buy" rating. This positive outlook from a reputable research firm has likely contributed to the recent bullish sentiment surrounding the stock.
Additionally, the Swiss National Bank has increased its stake in Biohaven, further bolstering investor confidence in the company's prospects. This move by a major institutional investor suggests a strong belief in Biohaven's future performance and growth potential.

Get the scoop on pre-market movers and shakers in the US stock market.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments
No comments yet